Advanced search
Publication Cover
Gynecological Endocrinology Volume 35, 2019 - Issue 6
Submit an article Journal homepage
578
Views
5
CrossRef citations to date
0
Altmetric
HORMONAL CONTRACEPTION AND RISK OF BREAST CANCER

Hormonal contraception and risk of breast cancer: a critical look

Patricio BarrigaSchool of Medicine, Finis Terrae University, Santiago, Chile;Correspondencepbarriga@uft
ORCID Iconhttp://orcid.org/0000-0002-3494-7556
ORCID Icon,
Paula VanhauwaertGynecologist, Clinica Alemana de Santiago, Santiago, Chile;
&
Arnaldo PorcileFaculty of Medicine, Universidad de Chile, Santiago, Chile.
Pages 460-462 | Received 11 Jun 2018, Accepted 13 Dec 2018, Published online: 26 Feb 2019

References

  • Bassuk SS, Manson JE. Oral contraceptives and menopausal hormone therapy: relative and attributable risk of cardiovascular disease, cancer, and other health outcomes. Ann Epidemiol. 2015;25:193–200.
  • Manson JE ,Aragaki AK, Rossouw JE. Menopausal hormone therapy and long-term all-cause and cause-specific mortality the women’s health initiative randomized trials. JAMA. 2017;318:927–38.
  • Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30.
  • Mørch LS, Skovlund CW, Hannaford PC, et al. Contemporary hormonal contraception and the risk of breast cancer. N Engl J Med. 2017;377:2228–2239.
  • Danaei G, Vander Hoorn S, Lopez AD, et al. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784–1793.
  • Kahlenborn C, Modugno F, Potter DM, et al. Uso de anticonceptivos orales como factor de riesgo de cáncer de mama premenopáusico: un metaanálisis. Mayo Clin Proc. 2006;81:1290–1302.
  • Hannaford PC, Iversen L, Macfarlane TV, et al. Mortality among contraceptive pill users: cohort evidence from Royal college of general practitioners’ oral contraception study. BMJ. 2010;340:c927.
  • Charlton BM, Rich-Edwards JW, Colditz GA, et al. Oral contraceptive use and mortality after 36 years of follow-up in the nurses’ health study: prospective cohort study. BMJ. 2014;349:g6356.
  • Ichida M, Kataoka A, Tsushima R, Taguchi T. No increase in breast cancer risk in Japanese women taking oral contraceptives: a case-control study investigating reproductive, menstrual and familial risk factors for breast cancer. Asian Pac J Cancer Prevent. 2015;16:3685–3690.
  • Gaffield ML, Kiarie J. WHO medical eligibility criteria update. Contraception. 2016;94(3):175. September (ref. 271 to 293).
  • Charlton BM. contraceptive use and mortality after 36 years of follow up interested nurse health study: prospective cohort study. Br Med J. 2014;349:6356.
  • Luo L, Luo B, Zheng Y, et al. Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia. Cochrane Database Syst Rev. 2013;CD009458.pub2.
  • Dominick S, Hickey M, Chin J, et al. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev. 2015;CD007245.
  • Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347:1713–1727.
  • Hankinson SE, Colditz GA, Manson JE, et al. A prospective study of oral contraceptive use and risk of breast cancer (Nurses Health Study, United States). Cancer Causes Control. 1997;8:65–72.
  • Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025–2032.
  • Kumle M, Weiderpass E, Braaten T, et al. Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish women’s lifestyle and health cohort study. Cancer Epidemiol Biomarkers Prev. 2002;11:1375–1381.
  • Dumeaux V, Alsaker E, Lund E. Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study. Int J Cancer. 2003;105:844–850.
  • Molina RL, Pace LE. A renewed focus on maternal health in the United States. N Engl J Med. 2017;377:1705–1707.
  • Aedo S, Cavada G, Blumel JE, et al. Women’s health initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. Menopause. 2015;22:1317–1322.
  • Singh S, Wulf D, Hussain R, et al. Abortion Worldwide: A Decade of Uneven Progress, New York: Guttmacher Institute; 2009. Available from: https://www.guttmacher.org/report/abortion-worldwide-decade-uneven-progress.
  • Royston P, Parmar MK. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Statist Med. 2011;30:2409–2421.
  • Royston P, Parmar MK. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Med Res Methodol. 2013;13:152.
  • Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95:S144–S150.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.